| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | myosin binding | 7.88e-04 | 85 | 10 | 2 | GO:0017022 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 4.51e-03 | 206 | 10 | 2 | GO:0140030 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.18e-03 | 749 | 10 | 3 | GO:0005509 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 2.11e-06 | 5 | 10 | 2 | GO:0048496 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 2.26e-04 | 47 | 10 | 2 | GO:0045494 | |
| GeneOntologyBiologicalProcess | retina homeostasis | 4.20e-04 | 64 | 10 | 2 | GO:0001895 | |
| GeneOntologyCellularComponent | USH2 complex | 1.24e-06 | 4 | 10 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | stereocilium membrane | 3.09e-06 | 6 | 10 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 3.09e-06 | 6 | 10 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 3.09e-06 | 6 | 10 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 3.09e-06 | 6 | 10 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 5.76e-06 | 8 | 10 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 2.30e-04 | 48 | 10 | 2 | GO:0032391 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.61e-04 | 278 | 10 | 3 | GO:0098858 | |
| GeneOntologyCellularComponent | stereocilium | 4.75e-04 | 69 | 10 | 2 | GO:0032420 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 6.07e-04 | 78 | 10 | 2 | GO:0001917 | |
| GeneOntologyCellularComponent | stereocilium bundle | 6.22e-04 | 79 | 10 | 2 | GO:0032421 | |
| GeneOntologyCellularComponent | ciliary transition zone | 6.54e-04 | 81 | 10 | 2 | GO:0035869 | |
| GeneOntologyCellularComponent | neuron projection membrane | 6.70e-04 | 82 | 10 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | basement membrane | 1.47e-03 | 122 | 10 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.91e-03 | 139 | 10 | 2 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.30e-03 | 153 | 10 | 2 | GO:0097731 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.13e-03 | 656 | 10 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.16e-03 | 658 | 10 | 3 | GO:0030312 | |
| GeneOntologyCellularComponent | ciliary basal body | 3.71e-03 | 195 | 10 | 2 | GO:0036064 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.75e-03 | 196 | 10 | 2 | GO:0097730 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.29e-03 | 210 | 10 | 2 | GO:0031256 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 4.82e-03 | 223 | 10 | 2 | GO:0098862 | |
| GeneOntologyCellularComponent | cilium | 7.56e-03 | 898 | 10 | 3 | GO:0005929 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.71e-02 | 431 | 10 | 2 | GO:0031253 | |
| GeneOntologyCellularComponent | cell leading edge | 2.26e-02 | 500 | 10 | 2 | GO:0031252 | |
| MousePheno | abnormal neck morphology | 4.81e-05 | 15 | 10 | 2 | MP:0012719 | |
| Domain | - | 1.29e-07 | 95 | 10 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 3.65e-06 | 219 | 10 | 4 | IPR013320 | |
| Domain | LAMININ_NTER | 3.08e-05 | 16 | 10 | 2 | PS51117 | |
| Domain | Laminin_N | 3.08e-05 | 16 | 10 | 2 | PF00055 | |
| Domain | Laminin_N | 3.08e-05 | 16 | 10 | 2 | IPR008211 | |
| Domain | LamNT | 3.08e-05 | 16 | 10 | 2 | SM00136 | |
| Domain | EGF_LAM_1 | 1.11e-04 | 30 | 10 | 2 | PS01248 | |
| Domain | EGF_LAM_2 | 1.11e-04 | 30 | 10 | 2 | PS50027 | |
| Domain | EGF_Lam | 1.52e-04 | 35 | 10 | 2 | SM00180 | |
| Domain | Laminin_EGF | 1.52e-04 | 35 | 10 | 2 | PF00053 | |
| Domain | LAM_G_DOMAIN | 1.80e-04 | 38 | 10 | 2 | PS50025 | |
| Domain | Laminin_EGF | 1.80e-04 | 38 | 10 | 2 | IPR002049 | |
| Domain | Laminin_G_2 | 1.99e-04 | 40 | 10 | 2 | PF02210 | |
| Domain | LamG | 2.41e-04 | 44 | 10 | 2 | SM00282 | |
| Domain | EGF_1 | 2.81e-04 | 255 | 10 | 3 | PS00022 | |
| Domain | Laminin_G | 4.20e-04 | 58 | 10 | 2 | IPR001791 | |
| Domain | Growth_fac_rcpt_ | 2.99e-03 | 156 | 10 | 2 | IPR009030 | |
| Domain | EGF | 6.64e-03 | 235 | 10 | 2 | SM00181 | |
| Domain | EGF-like_dom | 7.42e-03 | 249 | 10 | 2 | IPR000742 | |
| Domain | EGF-like_CS | 8.13e-03 | 261 | 10 | 2 | IPR013032 | |
| Domain | EGF_2 | 8.37e-03 | 265 | 10 | 2 | PS01186 | |
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 7.44e-08 | 2 | 10 | 2 | 28653555 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 34638692 | ||
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 15671307 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 16434480 | ||
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 2.23e-07 | 3 | 10 | 2 | 20440071 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 28761320 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 29142287 | ||
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 22147658 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 20502675 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 23055499 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 20301515 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 26401052 | ||
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 37066759 | ||
| Pubmed | Adenylyl cyclase 6 plays a minor role in the mouse inner ear and retina. | 4.46e-07 | 4 | 10 | 2 | 37127773 | |
| Pubmed | 4.46e-07 | 4 | 10 | 2 | 25406310 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 4.46e-07 | 4 | 10 | 2 | 18463160 | |
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 24334608 | ||
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 7.44e-07 | 5 | 10 | 2 | 16301216 | |
| Pubmed | 7.44e-07 | 5 | 10 | 2 | 17906286 | ||
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 20058854 | ||
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 21212183 | ||
| Pubmed | 1.79e-06 | 87 | 10 | 3 | 20801516 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 2.08e-06 | 8 | 10 | 2 | 19683999 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 3.34e-06 | 10 | 10 | 2 | 24618850 | |
| Pubmed | 3.34e-06 | 10 | 10 | 2 | 24239741 | ||
| Pubmed | 8.91e-06 | 16 | 10 | 2 | 17567809 | ||
| Pubmed | 1.12e-04 | 347 | 10 | 3 | 16033648 | ||
| Pubmed | 2.38e-04 | 81 | 10 | 2 | 20301590 | ||
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 7.71e-07 | 4 | 7 | 2 | 1244 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.75e-05 | 196 | 10 | 3 | M3008 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN | 4.97e-05 | 199 | 10 | 3 | M9423 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.01e-04 | 40 | 10 | 2 | M5887 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-04 | 275 | 10 | 3 | M5884 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 160 | 10 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-06 | 160 | 10 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.04e-06 | 185 | 10 | 3 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.17e-06 | 186 | 10 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.84e-06 | 191 | 10 | 3 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.98e-06 | 192 | 10 | 3 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.26e-06 | 194 | 10 | 3 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.45e-04 | 126 | 10 | 2 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.45e-04 | 126 | 10 | 2 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-04 | 132 | 10 | 2 | 82f312a561d9fdd2ebc2c25926dfc2b333ff0a4f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-04 | 132 | 10 | 2 | fe87cb22e13e17df29ad43327f1aa71361907582 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-04 | 134 | 10 | 2 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 145 | 10 | 2 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.88e-04 | 150 | 10 | 2 | 5b111ec11a642d63fafa7e1422e36f81a2776531 | |
| ToppCell | PND07-28-samps-Mesenchymal-Pericyte-pericyte_F|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.88e-04 | 150 | 10 | 2 | 2d0d6dc07dcfe28e3d7694c52d15d17dae2fd47b | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 5.48e-04 | 159 | 10 | 2 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.69e-04 | 162 | 10 | 2 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-04 | 164 | 10 | 2 | 01a7c335897128d3478b8b9b44fb461cab493084 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-04 | 166 | 10 | 2 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.04e-04 | 167 | 10 | 2 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.12e-04 | 168 | 10 | 2 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.12e-04 | 168 | 10 | 2 | 11ab08e373abe4bbd0f2134db38a2e8efa0eb159 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-04 | 169 | 10 | 2 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.19e-04 | 169 | 10 | 2 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-04 | 169 | 10 | 2 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-04 | 169 | 10 | 2 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-04 | 170 | 10 | 2 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.26e-04 | 170 | 10 | 2 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-04 | 170 | 10 | 2 | 28e22f9ef58423acc0fb8de1aff958b116dd33e9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.33e-04 | 171 | 10 | 2 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 171 | 10 | 2 | 20ac3de9c164b409b70a30a8b6544ea491ef7c0e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-04 | 172 | 10 | 2 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.56e-04 | 174 | 10 | 2 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.56e-04 | 174 | 10 | 2 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-04 | 174 | 10 | 2 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.56e-04 | 174 | 10 | 2 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.56e-04 | 174 | 10 | 2 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-04 | 174 | 10 | 2 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-04 | 175 | 10 | 2 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.63e-04 | 175 | 10 | 2 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 175 | 10 | 2 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 175 | 10 | 2 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-04 | 175 | 10 | 2 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-04 | 175 | 10 | 2 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-04 | 176 | 10 | 2 | 0fb6b57c3fffc93c40f4989007af4d522666c5e9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 176 | 10 | 2 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-04 | 177 | 10 | 2 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-04 | 177 | 10 | 2 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.78e-04 | 177 | 10 | 2 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-04 | 177 | 10 | 2 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.86e-04 | 178 | 10 | 2 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-04 | 178 | 10 | 2 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.86e-04 | 178 | 10 | 2 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.86e-04 | 178 | 10 | 2 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.86e-04 | 178 | 10 | 2 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-04 | 179 | 10 | 2 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-04 | 179 | 10 | 2 | cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-04 | 179 | 10 | 2 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-04 | 179 | 10 | 2 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 6.94e-04 | 179 | 10 | 2 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-04 | 179 | 10 | 2 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-04 | 179 | 10 | 2 | ac94d4c32402c9b856fab656ac1aff0ee12d152c | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 6.94e-04 | 179 | 10 | 2 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-04 | 180 | 10 | 2 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-04 | 180 | 10 | 2 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-04 | 180 | 10 | 2 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-04 | 180 | 10 | 2 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.09e-04 | 181 | 10 | 2 | 59527ad218e49386b04cabb97d53d2ed55a35961 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 7.09e-04 | 181 | 10 | 2 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.09e-04 | 181 | 10 | 2 | 6c55985e464cb0f5fb3362e9fd90351b671950f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 7.25e-04 | 183 | 10 | 2 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.25e-04 | 183 | 10 | 2 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-04 | 183 | 10 | 2 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.25e-04 | 183 | 10 | 2 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-04 | 183 | 10 | 2 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 7.25e-04 | 183 | 10 | 2 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.33e-04 | 184 | 10 | 2 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-04 | 184 | 10 | 2 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.33e-04 | 184 | 10 | 2 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-04 | 184 | 10 | 2 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-04 | 185 | 10 | 2 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-04 | 185 | 10 | 2 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-04 | 185 | 10 | 2 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-04 | 185 | 10 | 2 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 186 | 10 | 2 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.48e-04 | 186 | 10 | 2 | e93415b59dd89bc8a966dab0e0b65fe215933598 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-04 | 186 | 10 | 2 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-04 | 186 | 10 | 2 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.48e-04 | 186 | 10 | 2 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-04 | 187 | 10 | 2 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-04 | 187 | 10 | 2 | eb011a3d8a3025cebb0fba36d403be906305372c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.56e-04 | 187 | 10 | 2 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.56e-04 | 187 | 10 | 2 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| Drug | azidopine | 6.52e-05 | 28 | 10 | 2 | CID000656406 | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.54e-05 | 199 | 10 | 3 | 6475_DN | |
| Drug | 3-mercaptopropionic acid | 1.63e-04 | 44 | 10 | 2 | CID000006514 | |
| Drug | phenethanolamine | 1.78e-04 | 46 | 10 | 2 | CID000001000 | |
| Drug | ifenprodil | 4.25e-04 | 71 | 10 | 2 | CID000003689 | |
| Drug | sodium bicarbonate | 4.61e-04 | 74 | 10 | 2 | CID000010340 | |
| Drug | bu-b | 4.99e-04 | 77 | 10 | 2 | CID000351065 | |
| Drug | phenylethylamine | 6.66e-04 | 89 | 10 | 2 | CID000001001 | |
| Drug | tranylcypromine | 6.96e-04 | 91 | 10 | 2 | CID000005530 | |
| Drug | 2-nitroimidazole | 1.39e-03 | 129 | 10 | 2 | CID000010701 | |
| Drug | Mifepristone | 1.51e-03 | 553 | 10 | 3 | ctd:D015735 | |
| Drug | pyridoxal | 1.52e-03 | 135 | 10 | 2 | CID000001050 | |
| Drug | oltipraz | 1.57e-03 | 137 | 10 | 2 | CID000047318 | |
| Drug | AC1Q5UBL | 1.78e-03 | 146 | 10 | 2 | CID000005466 | |
| Drug | Nexus | 1.92e-03 | 152 | 10 | 2 | CID000098527 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 3.61e-05 | 27 | 10 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | Disorder of eye | 4.23e-05 | 212 | 10 | 3 | C0015397 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 8.42e-05 | 41 | 10 | 2 | DOID:10584 (is_implicated_in) | |
| Disease | Retinitis pigmentosa | 2.76e-04 | 74 | 10 | 2 | cv:C0035334 | |
| Disease | hearing impairment | 4.83e-04 | 98 | 10 | 2 | C1384666 | |
| Disease | Retinitis Pigmentosa | 5.44e-04 | 104 | 10 | 2 | C0035334 | |
| Disease | Ciliopathies | 6.08e-04 | 110 | 10 | 2 | C4277690 | |
| Disease | allergic rhinitis | 8.86e-04 | 133 | 10 | 2 | EFO_0005854 | |
| Disease | complement factor H-related protein 3 measurement | 1.42e-03 | 169 | 10 | 2 | EFO_0600056 | |
| Disease | ovarian carcinoma | 5.01e-03 | 321 | 10 | 2 | EFO_0001075 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFSAWVMPNANTNGF | 1356 | Q8WXG9 | |
| MASNNHWFQSSQVPS | 1 | Q96M93 | |
| PQNSSMARGFSWERY | 616 | Q16853 | |
| FSWRGYAQMTSVQND | 756 | Q16787 | |
| SSVSFYNWMSNAVGN | 2346 | Q2LD37 | |
| SPSENMWNTGSTYNL | 491 | Q86X55 | |
| NTFMYNDTGLQPWTQ | 4221 | O75445 | |
| NYRMSWTGPNNSSFQ | 516 | Q6P4F7 | |
| SGWATFQQMSPSRNF | 16 | Q4LDE5 | |
| EGYQLSSAMNFRWPQ | 226 | Q9UPZ9 | |
| QSSWNYNFMGVRHDP | 2276 | Q6P2Q9 |